NPI: 1356317192 · HARTFORD, CT 06112 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,951 | $931K |
| 2019 | 52,107 | $499K |
| 2020 | 33,659 | $278K |
| 2021 | 25,383 | $262K |
| 2022 | 21,445 | $318K |
| 2023 | 8,412 | $150K |
| 2024 | 2,560 | $4K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 65,192 | 5,184 | $956K |
| 83970 | 3,716 | 2,456 | $487K | |
| 82728 | 2,500 | 2,092 | $304K | |
| 83550 | 2,345 | 1,944 | $180K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 59,421 | 2,942 | $153K |
| 83540 | 2,585 | 2,135 | $140K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 29,312 | 2,271 | $68K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 4,442 | 824 | $62K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,228 | 811 | $25K |
| 85041 | 3,184 | 2,707 | $22K | |
| A4657 | Syringe, with or without needle, each | 3,706 | 3,154 | $19K |
| 85048 | 3,183 | 2,709 | $18K | |
| J1756 | Injection, iron sucrose, 1 mg | 7,815 | 1,978 | $10K |
| G0008 | Administration of influenza virus vaccine | 197 | 178 | $337.96 |
| 90674 | 101 | 90 | $36.79 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 449 | 251 | $0.00 |
| 90662 | 95 | 82 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,010 | 114 | $0.00 |
| 85045 | 24 | 24 | $0.00 | |
| 0011A | 12 | 12 | $0.00 |